MyFinsight
Home
Blog
About
Proceeds from
redemptions of cash in trust...
$99,311,220
Net cash provided by
(used in) investing...
$98,711,220
(142.70%↑ Y/Y)
Canceled cashflow
$600,000
Net change in cash
$5,393
(1119.47%↑ Y/Y)
Canceled cashflow
$98,705,827
Investment of cash into
trust account
$600,000
(-99.74%↓ Y/Y)
Extension deposits
$600,000
Proceeds from interim
note
$250,000
Net income
$1,726,897
(-51.26%↓ Y/Y)
Net cash (used in)
provided by financing...
-$98,461,220
(-142.53%↓ Y/Y)
Net cash used in
operating activities
-$244,607
(31.65%↑ Y/Y)
Canceled cashflow
$850,000
Canceled cashflow
$1,726,897
Payment to ordinary
shareholders for redemptions
$99,311,220
Interest earned on cash
and investments...
$1,863,831
(-53.47%↓ Y/Y)
Accounts payable and
accrued expenses
-$58,769
(-183.75%↓ Y/Y)
Prepaid expenses
$48,904
(0.00%↑ Y/Y)
Back
Back
Cash Flow
Drugs Made In America Acquisition Corp. (DMAA)
Drugs Made In America Acquisition Corp. (DMAA)
source: myfinsight.com